2022
DOI: 10.1016/j.onano.2022.100037
|View full text |Cite
|
Sign up to set email alerts
|

Hydrophobic@amphiphilic hybrid nanostructure of iron-oxide and graphene quantum dot surfactant as a theranostic platform

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 20 publications
0
2
0
Order By: Relevance
“…Tehrani Fateh et al prepared hybrid nanoparticles (Nps) from cetyl alcohol‐modified GQDs and iron oxide magnetic nanoparticles having magnetic, photoluminescent, targeting, and drug‐loading properties. Cell viability tests were performed with the hybrid NPs in two types of noncancerous and one type of cancer cell lines and in vivo toxicity was investigated in mice liver and heart (Tehrani Fateh et al, 2022). Chen et al developed a drug delivery platform by coating Fe 3 O 4 nanoparticles with chitosan, loading the drug doxorubicin into the composite, and further modifying the drug‐loaded composite with GQDs and aptamers.…”
Section: Carbon Quantum Dots In Drug Deliverymentioning
confidence: 99%
See 1 more Smart Citation
“…Tehrani Fateh et al prepared hybrid nanoparticles (Nps) from cetyl alcohol‐modified GQDs and iron oxide magnetic nanoparticles having magnetic, photoluminescent, targeting, and drug‐loading properties. Cell viability tests were performed with the hybrid NPs in two types of noncancerous and one type of cancer cell lines and in vivo toxicity was investigated in mice liver and heart (Tehrani Fateh et al, 2022). Chen et al developed a drug delivery platform by coating Fe 3 O 4 nanoparticles with chitosan, loading the drug doxorubicin into the composite, and further modifying the drug‐loaded composite with GQDs and aptamers.…”
Section: Carbon Quantum Dots In Drug Deliverymentioning
confidence: 99%
“…The smaller nanoparticles were cleared by the kidneys, while larger moved towards liver for further processing. The prime destination for the degradation of administered nanoparticles was the liver, where they were rapidly degraded and cleared from the bloodstream through rapid uptake by the macrophages (Karimi & Namazi, 2020; Tehrani Fateh et al, 2022; Zhang et al, 2016). Tatiana Da Ros et al reported that nanoparticles with size less than 32 nanometers were able to pass renal ultrafiltration barrier and the GQDs/CQDs were cleared off through urine (Hadad et al, 2021).…”
Section: Carbon Quantum Dots In Drug Deliverymentioning
confidence: 99%